 Fecal microbiota transplantation, FMT, has been used for centuries to treat various illnesses, but it wasn't until the late 1950s that it gained renewed interest, due to reports on its effectiveness in treating fulminant enterocolitis. In 2008, a double-blind randomized clinical trial showed that FMT was more effective than antibiotics in treating costridium difficile infections, leading to widespread acceptance of this treatment option. This article was authored by Albert K. Growne and Max Newdorp.